Cargando…
Improving management of glycaemic control in people with T2DM in primary care: estimation of the impact on the clinical complications and associated costs
BACKGROUND: To estimate the potential benefits in terms of avoided complications and cost reduction if the Spanish health system would encourage the intensification of treatment for better glycaemic control in adults with Type 2 diabetes from the current HbA1c target used in clinical practice of 68 ...
Autores principales: | Mata-Cases, M., Mahon, J., Mauricio, D., Franch-Nadal, J., Real, J., Hex, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448435/ https://www.ncbi.nlm.nih.gov/pubmed/32847581 http://dx.doi.org/10.1186/s12913-020-05360-w |
Ejemplares similares
-
Glycaemic control and antidiabetic treatment trends in primary care centres in patients with type 2 diabetes mellitus during 2007–2013 in Catalonia: a population-based study
por: Mata-Cases, Manel, et al.
Publicado: (2016) -
Older type 2 diabetic patients are more likely to achieve glycaemic and cardiovascular risk factors targets than younger patients: analysis of a primary care database
por: Barrot‐de la Puente, J., et al.
Publicado: (2015) -
Trends in the Degree of Control and Treatment of Cardiovascular Risk Factors in People With Type 2 Diabetes in a Primary Care Setting in Catalonia During 2007–2018
por: Mata-Cases, Manel, et al.
Publicado: (2022) -
Outcome of COVID-19 infection in people with diabetes mellitus or obesity in the primary care setting in Catalonia, Spain: A retrospective cohort study of the initial three waves
por: Mauricio, Dídac, et al.
Publicado: (2023) -
How Many Patients with Type 2 Diabetes Meet the Inclusion Criteria of the Cardiovascular Outcome Trials with SGLT2 Inhibitors? Estimations from a Population Database in a Mediterranean Area
por: Canivell, Silvia, et al.
Publicado: (2019)